anhedonia glp 1 Risk of depression with GLP‐1 receptor agonists use in overweight or obese adults with type 2 diabetes: A new‐user, active‐comparator cohort study How GLP-1s Affect the Brain

Clinical trial data showed patients taking oral Wegovy lost an average of 13.6% of body weight at 71 weeks, while comparable injectable GLP-1 trials have shown average weight loss to be between 15% to 20%

The need-to-know this morning Abeona Therapeutics said the FDA approved its cell-based gene therapy for patients with recessive dystrophic epidermolysis bulosa, a rare skin condition that causes blistering wounds

Int Urogynecol J Pelvic Floor Dysfunct 2003

The NRF2-deficient mice did not spontaneously develop skin lesions (Fig

Quality-Assured Ingredients Manufactured by OstroVit, known for high-quality, science-backed supplements

These agents exhibit anti-inflammatory, cardioprotective, and neuroprotective effects, suggesting a broader therapeutic potential